President Trump sent letters to 17 of the world's biggest prescription drugmakers last week calling on them to reduce prices ...

Major pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do in Europe and other peer countries, the so-called “Most Favored Nation” ...

In follow-up to the May 12th “Delivering Most Favored Nation Prescription Drug Pricing to American Patients” Executive Order, ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Our system provides the best of both worlds: development of new drugs and cheap options for most prescriptions. | Opinion ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a “most favored nation” pricing model for ...

The White House set a 60-day deadline for drugmakers to agree on “most favored nation” prices for Medicaid as well as for ...

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

Most Favored Nation’s War on R&D would mean fewer remedies and therapies. This is perfect for an aging, ailing nation in which 10,000 new baby boomers turn 65 and qualify for Medicare every day.